Bioprocess Engineering of Cells for Therapy

点击翻译按钮获取中文摘要

In the past 5 years, we have witnessed major cell and gene therapy advances, for example curing previously untreatable types of blindness and cancers. These are only the first of what should be a revolution in medicine, driven by hundreds of ongoing clinical trials of cellular therapies for other cancers, diabetes and cardiovascular diseases. The great promise of these emerging treatments comes with great challenges, many of those in the field of cell culture process engineering. The long-term goal of this research program is to develop technologies that will enable safer and more economical manufacture of cellular therapy products. This is essential to ensure that many promising emerging health care technologies actually become widely available to the patients who need them. Ultimately, increased access to safe and affordable cell culture products will improve the quality of many thousands of Canadian lives. UBC and Canadian multidisciplinary groups are among the leaders in this area of research. Exporting these technologies and knowledge should benefit populations around the world as well as translate into substantial commercial benefits for Canadians.